Impact of prior endocrine therapy on radiographic progression-free survival (rPFS) in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302 Meeting Abstract


Authors: Oudard, S.; Kheoh, T. S.; Yu, M. K.; Smith, M. R.; Small, E. J.; Mulders, P. F. A.; Fizazi, K.; Rathkopf, D. E.; Saad, F.; Scher, H. I.; Bellmunt, J.; Taplin, M. E.; Davis, I. D.; Schrijvers, D. L.; Protheroe, A.; Molina, A.; Griffin, T. W.; de Bono, J. S.; Ryan, C. J.
Abstract Title: Impact of prior endocrine therapy on radiographic progression-free survival (rPFS) in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
Meeting Title: 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 4 Suppl.
Meeting Dates: 2014 Jan 30-Feb 1
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-02-01
Language: English
ACCESSION: WOS:000335318100017
PROVIDER: wos
DOI: 10.1200/jco.2014.32.4_suppl.14
Notes: Meeting Abstract: 14 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf
  2. Howard Scher
    1130 Scher